Overview

Infectious Disease Testing Market Introduction:

Global infectious disease testing market to achieve beyond $24 billion mark by 2027 end, registering a CAGR of 5.8% during the forecast period of 2020-2027.

Infectious disease is caused by bacteria, virus and others and has a huge impact on healthcare systems of the countries. Infectious disease testing is the process of identification of causative organism for the primary diagnosis of diseases.Infectious diseases testing samples include blood, urine and other bodily fluids. Diagnosis is primary requisite for disease management, so infectious disease testing plays a very important role in primary healthcare settings.

Increasing epidemics of infectious diseases require continuous testing and led robust growth of the market. Infectious diseases have a huge impact on healthcare systems due to high disease burden. Because of this, government bodies made it mandatory to run infectious disease testing across different domains. It created potential opportunities for infectious disease testing manufacturers and boosted the growth of the market. Further, changing regulatory policies to mandate the infectious disease testing for the general population fuelled the growth of the market. Along with these, technology has integrated the existing manual operations and led to the development of a fully automated process. Others factors like increasing awareness among the general population regarding the drastic effects of infectious diseases have boosted the robust growth of the infectious disease testing market.

Developing economies made it mandatory for testing the general population regarding the infectious disease epidemics has boosted the growth of North America and Europe. North America infectious disease testing market accounts major share in the global market due to high penetration among the end users. It is followed by Europe and it witnessed a significant share due to stringent government policies. Asia Pacific and Latin America Infectious Disease Testing market is the most lucrative space for manufacturers due to high prevalence of infectious diseases. Rest of the world witnessed significant growth during the forecast period due to increasing awareness.

Infectious disease testing manufacturers include Abbott Laboratories, Becton, Dickinson And Company, Biomérieux Sa, Bio-rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Trinity Biotech, ChemBio Diagnostics Systems, Orasure Technologies, SEEGENE, Co-Diagnostics, Genetic Signatures.

Impact of COVID-19 on Infectious Disease Testing Market:

Many diagnostic test manufacturers have initiated to develop and commercialize devices that facilitate testing procedures outside lab settings. These kits are capable of detecting COVID-19 proteins from the respiratory samples such as throat swab and sputum or through serum or blood. But WHO has recommended to use these point-of-care tests specifically in research settings. The rapid diagnostic testing is capable of detecting the presence of antigens of the novel coronavirus from a respiratory tract sample. Such advancements shall contribute in the market growth.

Infectious Disease Testing Market Segmentation

By Product & Service

Assays, Kits, & Reagents
Instruments
Services & Software

By Technology

Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction (Pcr)
Isothermal Nucleic Acid Amplification Technology (Inaat)
Dna Sequencing & Next-generation Sequencing (Ngs)
Dna Microarray
Other Technologies

By Type of Testing

Laboratory Testing
POC Testing

By Disease Type

Hepatitis
Human Immunodeficiency Virus (Hiv)
Chlamydia Trachomatis Genital Infection And Gonorrhea (Ct/Ng)
Hospital-acquired Infections (Hais)
Human Papillomavirus (Hpv)
Tuberculosis (Tb)
Influenza
Others

By End User

Hospital/Clinical Laboratories
Reference Laboratories
Physician Offices
Academic/Research Institutes
Others

By Region

Europe
North America
APAC
Latin America
Rest of World

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Takeaways

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global infectious disease testing market on the basis of product & service, technology, by type of testing, by disease type, end user and region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and an overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com